查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1785847

全球生物可吸收血管支架市场

Bioresorbable Vascular Scaffolds
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 265 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球生物可吸收血管支架市场规模将达到 6.4 亿美元

全球生物可吸收血管支架市场规模预计在2024年达到4.225亿美元，预计2024年至2030年期间的复合年增长率为7.2%，到2030年将达到6.4亿美元。週边动脉应用是本报告分析的细分市场之一，预计其复合年增长率为8.6%，到分析期结束时规模将达到3.769亿美元。冠状动脉应用细分市场在分析期间的复合年增长率预计为5.3%。

美国市场规模估计为 1.151 亿美元，中国市场预计复合年增长率为 11.5%

美国生物可吸收血管支架市场规模预计2024年达到1.151亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到1.362亿美元，2024年至2030年的复合年增长率为11.5%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.5%和7.0%。在欧洲，德国的复合年增长率预计为4.8%。

全球生物可吸收血管支架市场—主要趋势与驱动因素摘要

为什么生物可吸收血管支架在心血管治疗上越来越受到青睐？

生物可吸收血管支架 (BVS) 正在彻底改变冠状动脉疾病 (CAD) 的治疗方式，它提供了一种临时的结构解决方案，该解决方案会随着时间的推移自然溶解，留下已癒合的血管。与永久留在动脉内的传统金属支架不同，生物可吸收支架旨在在关键的癒合期内提供机械支撑，然后逐渐降解以恢復正常的血管功能。这项新一代技术解决了永久性支架相关的长期併发症，包括晚期支架内血栓症、血管卡压和发炎。

全球心血管疾病的流行，加上对微创治疗日益增长的需求，推动了生物可吸收血管支架的应用。患者和心臟科医生越来越青睐这些装置，因为它们有可能改善长期疗效并减少重复干预的需求。此外，聚合物科学和生物可吸收金属合金的进步提高了支架的强度、降解控制和生物相容性，使生物可吸收支架 (BVS) 成为传统支架的有前景的替代品。随着医疗保健系统优先考虑以患者为中心且经济高效的解决方案，生物可吸收支架正逐渐成为介入性心臟病学的关键创新。

科技进步如何改善生物可吸收血管支架？

生物材料、支架设计和药物释放型技术的创新推动了生物可吸收血管支架的进步，提高了其安全性、有效性和临床性能。该领域最重要的进展之一是高强度生物可吸收聚合物的开发，例如聚左旋乳酸 (PLLA)，它能够提供足够的径向支撑，同时抑制其随时间推移的降解。此外，研究人员正在研究镁基生物可吸收支架，这种支架具有更高的机械强度和快速吸收性，从而缓解了聚合物在动脉内长期存在所带来的担忧。

另一个突破是药物释放型涂层的引入，透过在早期癒合阶段释放抗增殖药物（例如Sirolimus或Everolimus）来预防血管再阻塞。这些药物释放型生物可吸收支架已显示出良好的临床效果，可降低支架内血管再阻塞率，同时确保最佳的血管癒合。此外，计算建模和人工智慧驱动的最佳化技术增强了支架设计，使支架轮廓更纤薄，灵活性更高，从而减少了支架血栓症等併发症。这些技术进步正在进一步提高生物可吸收支架（BVS）的性能，并有望加速下一代设备在介入性心臟病学中的应用。

哪些市场趋势推动了生物可吸收血管支架产业的发展？

冠状动脉疾病盛行率的上升和经皮冠状动脉介入治疗 (PCI) 数量的增加是推动生物可吸收血管支架市场成长的最重要趋势之一。由于心血管疾病仍然是全球最大的死亡原因，医疗保健提供者正在优先考虑能够改善患者长期预后的创新解决方案。微创和患者友善治疗方法的转变也推动了生物可吸收血管支架的需求，而生物可吸收技术则能够满足减轻长期身体负担这一更广泛的目标。

影响市场的另一个关键趋势是监管部门对生物可吸收支架的支持力道不断增加。儘管前几代生物可吸收支架（BVS）曾面临支架血栓症形成和降解速度不理想的担忧，但近年来材料科学和临床数据的创新重新激发了监管机构和医疗专业人士的兴趣。此外，生物可吸收技术的应用范围已从冠状动脉介入扩展到周边动脉疾病(PAD) 和其他血管疾病，这正在开闢新的市场机会。随着临床试验不断检验BVS 的效用，以及更多下一代器械获得监管部门的核准，生物可吸收支架市场在已开发经济体和新兴经济体都将迎来显着扩张。

影响生物可吸收血管支架市场未来发展的关键成长动力有哪些？

生物可吸收血管支架市场的成长受到多种因素的推动，包括技术进步、临床应用的不断增加以及对患者长期疗效的日益关注。主要成长要素之一是心血管疾病负担的不断加重，这需要创新有效的治疗方案。患者群体的不断扩大，尤其是老化和高风险族群，预计将增加对生物可吸收支架的需求。

另一个影响市场的关键驱动因素是医疗设备公司和学术机构对研发 (R&D) 的大力投入。支架设计、吸收动力学和药物释放型能力的不断改进，正在提升生物可吸收支架 (BVS) 技术的临床可行性。此外，医疗保健机构、医疗机构和生技公司之间的策略联盟正在加速尖端生物可吸收支架的商业化。价值导向型医疗保健模式的日益普及，这种模式优先考虑患者的长期利益而非短期手术成本，预计也将推动对生物可吸收支架的需求。随着这些因素持续推动创新和应用，生物可吸收血管支架将重新定义冠状动脉和周边动脉疾病管理的未来，改善患者预后，同时降低长期医疗成本。

部分

应用（週边动脉应用、冠状动脉应用）、最终用途（医院最终用途、门诊护理中心 (ACS) 最终用途、专科诊所最终用途）

受访公司范例

  • Abbott Cardiovascular
  • BD
  • Biotronik AG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd
  • Meril Life Sciences
  • MicroPort
  • Reva Medical Inc
  • Shandong Huaan Biotechnology Co.,Ltd
  • Terumo Interventional Systems
  • WL Gore & Associates, Inc.
  • Zeus Inc

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP29609

Global Bioresorbable Vascular Scaffolds Market to Reach US$640.0 Million by 2030

The global market for Bioresorbable Vascular Scaffolds estimated at US$422.5 Million in the year 2024, is expected to reach US$640.0 Million by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Peripheral Artery Application, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$376.9 Million by the end of the analysis period. Growth in the Coronary Artery Application segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$115.1 Million While China is Forecast to Grow at 11.5% CAGR

The Bioresorbable Vascular Scaffolds market in the U.S. is estimated at US$115.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$136.2 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Bioresorbable Vascular Scaffolds Market - Key Trends & Drivers Summarized

Why Are Bioresorbable Vascular Scaffolds Gaining Momentum in Cardiovascular Treatments?

Bioresorbable vascular scaffolds (BVS) are revolutionizing the treatment of coronary artery disease (CAD) by offering a temporary structural solution that naturally dissolves over time, leaving behind a healed vessel. Unlike traditional metallic stents, which remain permanently in the artery, bioresorbable scaffolds are designed to provide mechanical support during the critical healing phase and then gradually degrade, restoring natural vessel function. This next-generation technology addresses long-term complications associated with permanent stents, such as late-stent thrombosis, vessel caging, and inflammation.

The growing global prevalence of cardiovascular diseases, coupled with the increasing demand for minimally invasive procedures, has propelled the adoption of bioresorbable vascular scaffolds. Patients and cardiologists are increasingly favoring these devices due to their potential to improve long-term outcomes and reduce the need for repeat interventions. Additionally, advancements in polymer science and bioresorbable metal alloys are enhancing scaffold strength, degradation control, and biocompatibility, making BVS a promising alternative to traditional stents. As healthcare systems prioritize patient-centric and cost-effective solutions, BVS is emerging as a key innovation in interventional cardiology.

How Are Technological Advancements Improving Bioresorbable Vascular Scaffolds?

Innovations in biomaterials, scaffold design, and drug-eluting technology are driving the evolution of bioresorbable vascular scaffolds, improving their safety, efficacy, and clinical performance. One of the most significant advancements in this field is the development of high-strength bioresorbable polymers, such as poly-L-lactic acid (PLLA), which provide sufficient radial support while ensuring controlled degradation over time. Additionally, researchers are exploring magnesium-based bioresorbable scaffolds that offer improved mechanical strength and faster resorption, reducing concerns related to prolonged polymer presence in the arteries.

Another major breakthrough is the incorporation of drug-eluting coatings that help prevent restenosis by releasing antiproliferative agents such as sirolimus or everolimus during the initial healing phase. These drug-eluting bioresorbable scaffolds have demonstrated promising clinical outcomes by reducing in-stent restenosis rates while ensuring optimal vascular healing. Furthermore, computational modeling and AI-driven optimization techniques are enhancing scaffold design, leading to thinner strut profiles and improved flexibility, which reduce complications such as scaffold thrombosis. As these technological advancements continue to refine BVS performance, the adoption of these next-generation devices is expected to accelerate in interventional cardiology.

Which Market Trends Are Driving Growth in the Bioresorbable Vascular Scaffolds Industry?

The increasing prevalence of coronary artery disease and the rising number of percutaneous coronary interventions (PCIs) are among the most significant trends fueling the growth of the bioresorbable vascular scaffold market. With cardiovascular diseases remaining the leading cause of mortality worldwide, healthcare providers are prioritizing innovative solutions that improve long-term patient outcomes. The demand for BVS is also being driven by a shift toward minimally invasive and patient-friendly interventions, where bioresorbable technology aligns with the broader goal of reducing long-term foreign material presence in the body.

Another key trend shaping the market is the increasing regulatory support for bioresorbable scaffolds. While earlier-generation BVS faced concerns over scaffold thrombosis and suboptimal degradation rates, recent innovations in material science and clinical data have led to renewed interest from regulatory agencies and healthcare professionals. Additionally, the expansion of bioresorbable technology beyond coronary interventions-into peripheral artery disease (PAD) and other vascular conditions-is opening new market opportunities. As clinical trials continue to validate the benefits of BVS, and more next-generation devices receive regulatory approvals, the market is poised for significant expansion in both developed and emerging economies.

What Are the Key Growth Drivers Shaping the Future of the Bioresorbable Vascular Scaffolds Market?

The growth in the bioresorbable vascular scaffold market is driven by multiple factors, including technological advancements, increasing clinical adoption, and a growing emphasis on long-term patient outcomes. One of the primary growth drivers is the rising burden of cardiovascular diseases, which necessitates innovative and effective treatment options. As patient populations expand, particularly in aging demographics and high-risk groups, the demand for bioresorbable scaffolds is expected to increase.

Another crucial driver shaping the market is the strong investment in research and development (R&D) by medical device companies and academic institutions. Continuous improvements in scaffold design, resorption kinetics, and drug-eluting capabilities are enhancing the clinical feasibility of BVS technology. Additionally, strategic collaborations between healthcare providers, medical institutions, and biotech firms are accelerating the commercialization of advanced bioresorbable scaffolds. The increasing adoption of value-based healthcare models, which prioritize long-term patient benefits over short-term procedural costs, is also expected to boost the demand for BVS. As these factors continue to drive innovation and adoption, bioresorbable vascular scaffolds are set to redefine the future of coronary and peripheral artery disease management, improving patient outcomes while reducing long-term healthcare costs.

SCOPE OF STUDY:

The report analyzes the Bioresorbable Vascular Scaffolds market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Peripheral Artery Application, Coronary Artery Application); End-Use (Hospitals End-Use, Ambulatory Care Centers (ACS) End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Cardiovascular
  • BD
  • Biotronik AG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd
  • Meril Life Sciences
  • MicroPort
  • Reva Medical Inc
  • Shandong Huaan Biotechnology Co.,Ltd
  • Terumo Interventional Systems
  • W. L. Gore & Associates, Inc.
  • Zeus Inc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Bioresorbable Vascular Scaffolds - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cardiovascular Diseases Throws the Spotlight on Bioresorbable Vascular Scaffolds as a Revolutionary Stent Alternative
    • Shift Toward Minimally Invasive and Restorative Therapies Drives Demand for BVS in Coronary Interventions
    • Clinical Preference for Temporary Vessel Support Solutions Strengthens the Business Case for Bioresorbable Scaffolds
    • Limitations of Traditional Drug-Eluting Stents (DES) Expand Addressable Market Opportunity for BVS Technologies
    • Growing Emphasis on Natural Vessel Healing and Long-Term Vascular Restoration Fuels Adoption of BVS Devices
    • Technological Advancements in Polymer and Magnesium-Based Materials Propel Innovation in Scaffold Design and Performance
    • Increasing Use of Intravascular Imaging Techniques Enhances Precision Deployment and Optimized Outcomes of BVS
    • Rising Focus on Reducing Late-Stent Thrombosis Risk Spurs Clinical Interest in Fully Resorbable Scaffold Solutions
    • Next-Generation BVS Systems with Improved Radial Strength and Resorption Kinetics Accelerate Clinical Acceptance
    • Surge in Demand for Scaffold Solutions in Younger Patient Populations Propels Growth of Bioresorbable Stent Adoption
    • Healthcare System Focus on Reducing Long-Term Reintervention Rates Supports Broader Adoption of BVS
    • Emergence of Hybrid Scaffolds and Drug-Eluting Bioresorbable Technologies Opens New Avenues for Competitive Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bioresorbable Vascular Scaffolds Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Peripheral Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Peripheral Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Peripheral Artery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coronary Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coronary Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Coronary Artery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030

IV. COMPETITION